The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Travere Therapeutics Inc (NASDAQ: TVTX) closed at $18.07 in the last session, up 5.86% from day before closing price of $17.07. In other words, the price has increased by $5.86 from its previous closing price. On the day, 1.38 million shares were traded. TVTX stock price reached its highest trading level at $18.4525 during the session, while it also had its lowest trading level at $17.315.
Ratios:
We take a closer look at TVTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.68 and its Current Ratio is at 1.71.
On October 21, 2024, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $9 to $27.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 03 ’25 when Inrig Jula sold 2,066 shares for $19.10 per share. The transaction valued at 39,461 led to the insider holds 59,883 shares of the business.
Inrig Jula sold 440 shares of TVTX for $8,254 on Jan 06 ’25. The CHIEF MEDICAL OFFICER now owns 59,443 shares after completing the transaction at $18.76 per share. On Dec 26 ’24, another insider, Calvin Sandra, who serves as the SVP, CHIEF ACCOUNTING OFFICER of the company, sold 15,000 shares for $17.22 each. As a result, the insider received 258,277 and left with 54,927 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TVTX now has a Market Capitalization of 1572709888 and an Enterprise Value of 1535357184. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.73. Its current Enterprise Value per Revenue stands at 7.547 whereas that against EBITDA is -6.431.
Stock Price History:
The Beta on a monthly basis for TVTX is 0.72, which has changed by 0.92229724 over the last 52 weeks, in comparison to a change of 0.22212577 over the same period for the S&P500. Over the past 52 weeks, TVTX has reached a high of $20.33, while it has fallen to a 52-week low of $5.12. The 50-Day Moving Average of the stock is -0.67%, while the 200-Day Moving Average is calculated to be 51.24%.
Shares Statistics:
According to the various share statistics, TVTX traded on average about 1.28M shares per day over the past 3-months and 1136390 shares per day over the past 10 days. A total of 87.03M shares are outstanding, with a floating share count of 85.86M. Insiders hold about 1.35% of the company’s shares, while institutions hold 96.38% stake in the company. Shares short for TVTX as of 1735603200 were 8719387 with a Short Ratio of 6.83, compared to 1732838400 on 7574947. Therefore, it implies a Short% of Shares Outstanding of 8719387 and a Short% of Float of 11.1.
